Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TCGXTCGX Acquisition Corp.

Nasdaq · CIK 0002137965
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts59

Identity from submissions API

NameTCGX Acquisition Corp.
CIK0002137965
TickersTCGX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone(415) 260-2047
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
UGLAND HOUSE
PO BOX 309
GRAND CAYMAN
94301
Cayman Islands
E9
KY1-1104
Mailing address
UGLAND HOUSE
PO BOX 309
GRAND CAYMAN
94301
Cayman Islands
E9
KY1-1104

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

29 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128726 005-95867 261563801 34 14633
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-464039 005-95867 261563394 34 121141
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-007955 005-95867 261555984 34 14987
2026-11-09 10-Q 10-Q 0001193125-26-453559 001-43434 261535881 34 5005755 1 1
2026-11-09 425 425 0001193125-26-452777 001-43434 261534115 34 22272
2026-11-02 425 425 0001193125-26-443618 001-43434 261512228 34 21123
2026-10-19 425 425 0001193125-26-425374 001-43434 261469857 34 135148
2026-10-19 425 425 0001193125-26-425370 001-43434 261469852 34 22765
2026-10-19 425 425 0001193125-26-424760 001-43434 261467711 34 5869412
2026-10-19 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-26-424754 001-43434 261467699 34 6374170 1 1
2026-09-10 10-Q 10-Q 0001193125-26-387873 001-43434 261371159 34 3225404 1 1
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000226 005-95867 261273581 34 18963
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-002072 005-95867 261268413 34 38512
2026-08-12 8-K 8-K 8.01,9.01 0001193125-26-347043 001-43434 261268292 34 248589 1 1
2026-08-06 4 4 0001193125-26-338403 7059
2026-08-06 3/A 3/A 0001193125-26-338388 7358
2026-08-06 8-K 8-K 1.01,3.02,5.02,5.03,8.01,9.01 0001193125-26-338268 001-43434 261249793 34 1334591 1 1
2026-08-06 424B4 424B4 0001193125-26-336098 333-297569 261245532 33 1658578
2026-08-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002536 333-297569 261241080 33 1907
2026-08-04 3 3 0001193125-26-333338 19733
2026-08-04 3 3 0001193125-26-333337 21514
2026-08-04 3 3 0001193125-26-333336 21351
2026-08-04 3 3 0001193125-26-333335 20969
2026-08-04 3 3 0001193125-26-333334 21310
2026-08-04 CERT 8A_CERT_TCGX_0002137965.pdf 0001354457-26-000754 001-43434 261237784 34 181606
2026-08-04 8-A12B 8-A12B 0001193125-26-332291 001-43434 261237153 34 14128
2026-07-31 S-1/A S-1/A 0001193125-26-328576 333-297569 261228608 33 108845
2026-07-20 S-1 S-1 0001193125-26-308950 333-297569 261187005 33 5059614 1 1
2026-06-23 DRS filename1.htm 0001193125-26-278885 377-09499 261109943 33 1711375

Latest XBRL company facts

One latest value per concept from companyfacts (59 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
ffd NetFeeAmt NetFeeAmt USD 11,911.13 2026-07-20 S-1 2026-07-20 0001193125-26-308950
ffd TtlFeeAmt TtlFeeAmt USD 11,911.13 2026-07-20 S-1 2026-07-20 0001193125-26-308950
ffd TtlOfferingAmt TtlOfferingAmt USD 86.25M 2026-07-20 S-1 2026-07-20 0001193125-26-308950
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-20 S-1 2026-07-20 0001193125-26-308950
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-20 S-1 2026-07-20 0001193125-26-308950
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 295,977 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 6,012 2026-06-30 2026 Q2 10-Q 2026-09-10 0001193125-26-387873
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap Assets Assets USD 89.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap AssetsCurrent Assets, Current USD 2.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap AssetsHeldInTrustCurrent Assets Held-in-trust, Current USD 86.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 86.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap Cash Cash USD 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 2.67M 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 246,383 2026-06-30 2026 Q2 10-Q 2026-09-10 0001193125-26-387873
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 3.45M 2026-08-06 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.04 2026-05-26 2026-06-30 2026 Q2 10-Q 2026-09-10 0001193125-26-387873
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.04 2026-05-26 2026-06-30 2026 Q2 10-Q 2026-09-10 0001193125-26-387873
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 526,749 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 270,796 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 6,012 2026-05-26 2026-06-30 2026 Q2 10-Q 2026-09-10 0001193125-26-387873
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -22,500 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap InterestIncomeOther Interest Income, Other USD 483,311 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 483,311 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap Liabilities Liabilities USD 4.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 89.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap LiabilitiesCurrent Liabilities, Current USD 648,979 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 89.29M 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -86.25M 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -365,569 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -43,438 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 483,311 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -526,749 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap OtherDeferredCostsNet Other Deferred Costs, Net USD 662,054 2026-08-06 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 32,232 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 462,086 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 86.25M 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 102,500 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 95,605 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 86.25M 2026-08-06 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 84.53M 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 5.22M 2026-05-26 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -1.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 25,000 2026-05-26 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 6.28M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 86.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 10.06 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 8.63M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453559
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.88M 2026-05-26 2026-06-30 2026 Q2 10-Q 2026-09-10 0001193125-26-387873
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.88M 2026-05-26 2026-06-30 2026 Q2 10-Q 2026-09-10 0001193125-26-387873

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →